Mitsubishi UFJ Asset Management Co. Ltd. Grows Position in Waters Corporation $WAT

Mitsubishi UFJ Asset Management Co. Ltd. grew its stake in shares of Waters Corporation (NYSE:WAT) by 6.5% during the 3rd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 118,869 shares of the medical instruments supplier’s stock after purchasing an additional 7,297 shares during the period. Mitsubishi UFJ Asset Management Co. Ltd.’s holdings in Waters were worth $35,638,000 at the end of the most recent reporting period.

A number of other large investors have also made changes to their positions in WAT. Root Financial Partners LLC acquired a new stake in shares of Waters in the third quarter valued at about $26,000. ANTIPODES PARTNERS Ltd acquired a new stake in shares of Waters during the 3rd quarter valued at approximately $26,000. Hantz Financial Services Inc. boosted its stake in shares of Waters by 115.4% during the 3rd quarter. Hantz Financial Services Inc. now owns 112 shares of the medical instruments supplier’s stock worth $34,000 after acquiring an additional 60 shares in the last quarter. CYBER HORNET ETFs LLC acquired a new stake in shares of Waters in the 2nd quarter worth approximately $53,000. Finally, MUFG Securities EMEA plc purchased a new position in Waters in the 2nd quarter valued at approximately $61,000. Hedge funds and other institutional investors own 94.01% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts recently issued reports on WAT shares. Citigroup started coverage on Waters in a report on Tuesday, February 10th. They set a “buy” rating and a $425.00 price objective for the company. William Blair began coverage on Waters in a research note on Monday, January 5th. They set an “outperform” rating for the company. UBS Group lowered their price objective on shares of Waters from $395.00 to $370.00 and set a “neutral” rating on the stock in a research note on Tuesday, February 10th. TD Cowen restated a “hold” rating on shares of Waters in a research report on Wednesday, November 5th. Finally, Bank of America reduced their price target on shares of Waters from $410.00 to $350.00 and set a “neutral” rating on the stock in a report on Tuesday, February 10th. Two equities research analysts have rated the stock with a Strong Buy rating, ten have assigned a Buy rating and nine have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $393.84.

Waters Trading Down 1.2%

Shares of WAT stock opened at $318.99 on Monday. The firm has a 50-day moving average price of $368.77 and a 200 day moving average price of $351.02. Waters Corporation has a twelve month low of $275.05 and a twelve month high of $414.15. The company has a market capitalization of $31.29 billion, a price-to-earnings ratio of 29.62, a PEG ratio of 2.20 and a beta of 1.20. The company has a current ratio of 1.73, a quick ratio of 1.27 and a debt-to-equity ratio of 0.37.

Waters (NYSE:WAT) last released its quarterly earnings results on Monday, February 9th. The medical instruments supplier reported $4.53 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.50 by $0.03. The company had revenue of $932.36 million for the quarter, compared to analysts’ expectations of $928.17 million. Waters had a net margin of 20.30% and a return on equity of 34.79%. The firm’s revenue for the quarter was up 6.9% compared to the same quarter last year. During the same period last year, the company earned $4.10 EPS. Waters has set its FY 2026 guidance at 14.300-14.500 EPS and its Q1 2026 guidance at 2.250-2.350 EPS. Research analysts forecast that Waters Corporation will post 12.86 earnings per share for the current fiscal year.

Waters Company Profile

Waters Corporation is a global provider of analytical instruments, software and services for laboratory and research applications. The company designs, manufactures and sells technologies centered on liquid chromatography, mass spectrometry, separation science, and related sample preparation and detection systems. Its product portfolio includes chromatographs, mass spectrometers, columns and consumables, laboratory informatics and workflow software, as well as technical support and training services that help customers run and interpret complex analyses.

Waters serves a wide range of end markets that include pharmaceutical and biotechnology companies, contract research and testing laboratories, academic and government research institutions, clinical diagnostics, food and environmental testing, and industrial and chemical manufacturers.